Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
Xiuying TangJie GongPublished in: Cardiology research and practice (2022)
For AMI patients undergoing PCI, TMZ reduced circulating biomarkers of myocardial infarction, reduced values of ALT, AST, and glucose, and improved cardiac function compared with the control group.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- patients undergoing
- left ventricular
- st segment elevation myocardial infarction
- acute coronary syndrome
- coronary artery disease
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- atrial fibrillation
- heart failure
- coronary artery bypass
- type diabetes
- combination therapy
- skeletal muscle
- clinical evaluation
- smoking cessation